Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

References for PMC Articles for PubMed (Select 19285945)

1.

Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1.

Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, Abramov AY, Tinker A, Duchen MR.

Cell Metab. 2008 Jul;8(1):13-25. doi: 10.1016/j.cmet.2008.06.001.

2.

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AY, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, Downward J, Mansfield L, Jat P, Taylor J, Heales S, Duchen MR, Latchman D, Tabrizi SJ, Wood NW.

PLoS One. 2008 Jun 18;3(6):e2455. doi: 10.1371/journal.pone.0002455. Erratum in: PLoS ONE. 2008;3(7). doi: 10.1371/annotation/17d5aaa1-c6d8-4aad-a9a4-56b2c1220c83. Abramov, Andrey S Y [corrected to Abramov, Andrey Y]. PLoS ONE. 2008;3(7). doi: 10.1371/annotation/ba489c2a-5cf2-481c-aff7-d2c8c4ecdcfa.

3.

Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.

Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, Slack RS, Fraser P, Cookson MR, Tandon A, Park DS.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1716-21. doi: 10.1073/pnas.0705363105. Epub 2008 Jan 24.

4.

Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Exner N, Treske B, Paquet D, Holmström K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D, Hoepken HH, Gasser T, Krüger R, Winklhofer KF, Vogel F, Reichert AS, Auburger G, Kahle PJ, Schmid B, Haass C.

J Neurosci. 2007 Nov 7;27(45):12413-8.

5.

Targeted polyphosphatase expression alters mitochondrial metabolism and inhibits calcium-dependent cell death.

Abramov AY, Fraley C, Diao CT, Winkfein R, Colicos MA, Duchen MR, French RJ, Pavlov E.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18091-6. Epub 2007 Nov 6.

6.

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.

Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J.

Nat Cell Biol. 2007 Nov;9(11):1243-52. Epub 2007 Sep 30.

PMID:
17906618
7.
8.

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.

Pridgeon JW, Olzmann JA, Chin LS, Li L.

PLoS Biol. 2007 Jul;5(7):e172. Epub 2007 Jun 19.

9.

Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?

Scheele C, Nielsen AR, Walden TB, Sewell DA, Fischer CP, Brogan RJ, Petrovic N, Larsson O, Tesch PA, Wennmalm K, Hutchinson DS, Cannon B, Wahlestedt C, Pedersen BK, Timmons JA.

FASEB J. 2007 Nov;21(13):3653-65. Epub 2007 Jun 12.

10.

Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, Bonsi P, Zhang C, Pothos EN, Shen J.

Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11441-6. Epub 2007 Jun 11.

11.

'Rejuvenation' protects neurons in mouse models of Parkinson's disease.

Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ.

Nature. 2007 Jun 28;447(7148):1081-6. Epub 2007 Jun 10.

PMID:
17558391
12.

Calcium and neurodegeneration.

Mattson MP.

Aging Cell. 2007 Jun;6(3):337-50. Epub 2007 Feb 28. Review.

13.

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B.

Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8. Epub 2006 Jul 3.

14.

Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.

Muqit MM, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E, Eaton S, Payne Smith MD, Venner K, Matilla A, Healy DG, Gilks WP, Lees AJ, Holton J, Revesz T, Parker PJ, Harvey RJ, Wood NW, Latchman DS.

J Neurochem. 2006 Jul;98(1):156-69.

PMID:
16805805
15.

Mitochondrial dynamics and Ca2+ signaling.

Szabadkai G, Simoni AM, Bianchi K, De Stefani D, Leo S, Wieckowski MR, Rizzuto R.

Biochim Biophys Acta. 2006 May-Jun;1763(5-6):442-9. Epub 2006 Apr 20. Review.

16.

PINK1 protein in normal human brain and Parkinson's disease.

Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, Latchman DS, Holton JL, Wood NW, Revesz T.

Brain. 2006 Jul;129(Pt 7):1720-31. Epub 2006 May 15.

17.

Expression and modulation of an NADPH oxidase in mammalian astrocytes.

Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, Duchen MR.

J Neurosci. 2005 Oct 5;25(40):9176-84.

18.

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G.

Hum Mol Genet. 2005 Nov 15;14(22):3477-92. Epub 2005 Oct 5.

19.

Oxidative stress in neurodegeneration: cause or consequence?

Andersen JK.

Nat Med. 2004 Jul;10 Suppl:S18-25. Review.

PMID:
15298006
20.

Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW.

Science. 2004 May 21;304(5674):1158-60. Epub 2004 Apr 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk